Skip to main content
Advertisement
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Population Health
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Population Health
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
ADVERTISEMENT
Bridget Godwin
Treatment Persistence Among Anti-TNF-Experienced Patients With Ulcerative Colitis Switching to Ustekinumab or Cycling to Another Anti-TNF Agent
1 Analysis Group Inc., Montréal, Quebec, Canada; 2 Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, United States.
Maryia Zhdanava , MA;
Sumesh Kachroo ;
Porpong Boonmak ;
Sabree Burbage ;
Aditi Shah , MA;
Patrick Lefebvre , MA;
Dominic Pilon , MA;
Bridget Godwin ;
01/11/2024
Featured Webinar
Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications
Advertisement
Advertisement
Advertisement
Advertisement
Upcoming Events
November 6 – November 8
November 7 – November 10
November 8
November 8 – November 10
November 13 – November 16
November 14 – November 15
November 23 – November 24
December 4 – December 5
December 6 – December 7
December 9 – December 11
See Full Calendar
Advertisement
Advertisement
Advertisement